Ottawa's push for lower drug costs may hurt patients, stunt innovation
Fox 40 TV (Canada)
“The federal government is potentially on a path that will limit access of Canadians to new life-saving drugs, while further discouraging the discovery of new medicines,” said Steven Globerman, professor emeritus at Western Washington University, Fraser Institute senior fellow and study co-author.
Click the heart to favorite
Thursday, January 24, 2019 - 9:49am